Lifecare

Less than 1K followers

LIFE

Oslo Børs

Medical Equipment & Services

Health Care

Overview

Investor consensus

Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Market cap

-

Turnover

-

Revenue

9.67M

EBIT %

-876.63 %

P/E

-

Dividend yield-%

-

Financial calendar

19.2

2026

Annual report '25

23.4

2026

General meeting '26

14.5

2026

Interim report Q1'26

All

Press releases

ShowingAll content types

Regulatory press release11/13/2025, 9:28 AM

LIFE: Financial calendar

Regulatory press release11/12/2025, 7:34 PM

Minutes from Extraordinary General Meeting

Regulatory press release11/12/2025, 6:00 AM

LIFE: Lifecare ASA Q3 2025 results

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release11/6/2025, 6:00 AM

Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results

Press release11/5/2025, 6:00 AM

Lifecare shares key learnings from ongoing longevity study LFC-SEN-002

Press release10/28/2025, 6:00 AM

Lifecare receives update from NOMA on handling time for first-in-human study application

Regulatory press release10/22/2025, 12:00 PM

LIFECARE ASA: Extraordinary General Meeting

Press release10/22/2025, 10:50 AM

DNB Carnegie Access: Lifecare ASA: Withdrawing fair value

Regulatory press release10/22/2025, 5:16 AM

Lifecare ASA: Key information relating to the proposed partially underwritten rights issue

Regulatory press release10/22/2025, 5:15 AM

Lifecare ASA: Proposed partially underwritten rights issue

Press release9/24/2025, 5:00 AM

Lifecare strengthens miniaturisation roadmap with new patent applications

Press release9/15/2025, 5:00 AM

LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY

Press release8/27/2025, 5:00 AM

Reconfirmed positive results in veterinary study support path toward market entry

Press release8/20/2025, 1:41 PM

DNB Carnegie Access: Lifecare ASA: Progressing well, with financing on the agenda – Q2 review

Regulatory press release8/20/2025, 5:00 AM

LIFE: Lifecare ASA Q2 2025 results

Press release8/13/2025, 5:47 AM

Lifecare advances CE mark preparation for its groundbreaking medical device

Press release8/12/2025, 12:35 PM

Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST

Press release8/5/2025, 5:00 AM

Lifecare receives ethics approval to initiate first-in-human trial in Norway

Press release7/8/2025, 5:00 AM

Lifecare achieves full radio frequency compliance for CGM implant – clearing the way for CE mark of electronics

Press release7/1/2025, 5:00 AM

Lifecare advances electromagnetic compatibility compliance testing for CGM implant

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.